Glioma
📧 Sign up to get email alerts when something new happens for Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Cryoablation of Brain Neoplasm [NA]
An Erasmus Medical Center-sponsored clinical trial is evaluating cryoablation for brain neoplasms, currently enrolling by invitation. The co…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Surgical Suction Aspirates Fluorescence Measurement
A recruiting clinical trial at Kuopio University Hospital is evaluating fluorescence measurement of surgical suction aspirates in patients w…
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: A Microdose Evaluation Study of ABY-029 in Recurrent Glioma [EARLY_Phase 1]
A microdose Phase 1 study evaluating ABY-029 in recurrent glioma has completed, with results posted on 2024-12-13.
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Clinical Relevance of Detecting Molecular Abnormalities in Glial Tumor Exosomes [NA]
Clinical trial update on detecting molecular abnormalities in exosomes from glial tumors (glioma) and their clinical relevance. The study is…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: MicroRNAs in Patients With Neurofibromatosis Type 1
Completed clinical trial evaluating microRNAs in patients with Neurofibromatosis Type 1, including glioma cases.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)
A clinical trial update for the SOLOMON brain tumor monitoring cohort sponsored by Seoul National University Hospital; the study is currentl…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: PERMA-Based Intervention on Negative Emotions, Adherence, and Complications in Postoperative Glioma Patients [NA]
A clinical trial update reports on a PERMA-based intervention to address negative emotions, adherence, and postoperative complications in gl…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: Metabolic Characterization of Space Occupying Lesions of the Brain
A clinical trial from Insel Gruppe AG and University Hospital Bern aims to metabolically characterize space-occupying brain lesions, with a …
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma [Phase 1]
Phase 1 trial evaluating neo-adjuvant glioma lysate vaccines in WHO Grade II glioma has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Measuring Fatty Acid Oxidation in Gliomas Using 18F-FPIA PET/MRI
Completed clinical trial evaluating fatty acid oxidation in gliomas using the PET tracer 18F-FPIA with MRI. Results were posted on 2024-11-2…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Reducing Cognitive Impairment in Glioma with Repetitive Transcranial Magnetic Stimulation and Cognitive Strategy Training [NA]
A study combining repetitive transcranial magnetic stimulation and cognitive strategy training to reduce cognitive impairment in glioma pati…
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Resting-State Functional MRI in Glioma Patients Before and After Surgery [NA]
This completed clinical trial used resting-state functional MRI to assess glioma patients before and after surgical resection.
-
CLINICAL_TRIALS trial_result · 2024-11-15Clinical Trial Update: Brain Tumor Intraoperative Ultrasound Database
The Brain Tumor Intraoperative Ultrasound Database study has completed its clinical trial.
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients
This completed trial reports the metabolomic profiles in blood and cerebrospinal fluid from patients with glioma, including glioblastoma.
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: A Dose-Escalation Study in Participants With Recurrent Malignant Glioma [Phase 1]
Phase 1 dose-escalation trial in recurrent malignant glioma conducted by Eli Lilly has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: PARP Inhibition for Gliomas (PI-4G or π4g) [Phase 2]
Phase 2 trial of a PARP inhibitor for gliomas was terminated, with results posted in 2024, evaluating recurrent glioblastoma, recurrent astr…
-
CLINICAL_TRIALS approval · 2024-11-05Clinical Trial Update: Vorasidenib Expanded Access Program
Vorasidenib’s expanded access program update notes that vorasidenib has been approved for marketing for glioma recurrence.
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the combination of tumor-infiltrating lymphocyte (TIL) therapy with pembrolizumab for advanced brai…
-
EMA approval · 2024-10-30EMA Authorised: Gliolan (5-aminolevulinic acid hydrochloride) — Photonamic GmbH & Co. KG
The EMA authorised Gliolan (5-aminolevulinic acid hydrochloride) for use in glioma, with Photonamic GmbH & Co. KG as the marketing authoriza…
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Characterization of Metabolic Changes in the Glioma Tumor Tissue Induced by Transient Fasting (ERGO3) [NA]
A clinical trial update on ERGO3 investigates metabolic changes in glioma tumor tissue induced by transient fasting; the study is currently …
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Short Term Outcomes After PRoton and PhotoN RadiOtherapy for IDH Mutated Grade 2 and 3 Gliomas
A clinical trial update describing short-term outcomes from proton and photon radiotherapy for IDH-mutant grade 2-3 gliomas; the study is cu…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma [Phase 1, Phase 2]
Regeneron’s cemiplimab (REGN2810) was studied in pediatric patients with relapsed/refractory solid tumors and CNS tumors, including a safety…
-
CLINICAL_TRIALS withdrawal · 2024-10-09Clinical Trial Update: StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord [Phase 1]
Phase 1 trial evaluating StrataXRT to prevent radiation dermatitis in pediatric patients undergoing brain or spinal irradiation has been wit…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Development of an Artificial Intelligence Model for Optimising Therapy in Gliomas Gliomas
An ongoing clinical trial is developing an artificial intelligence model to optimize therapy for gliomas, with recruitment currently underwa…
-
CLINICAL_TRIALS research · 2024-09-24Clinical Trial Update: Monitoring of Patients With Low-grade Gliomas Using Circulating miRNA
A recruiting study evaluating circulating microRNA as biomarkers to monitor patients with low-grade gliomas.